LIQUID BIOPSY FOR EARLY, NON‐INVASIVE DIAGNOSIS OF EBV‐POSITIVE BURKITT LYMPHOMA IN RESOURCE LIMITED SETTINGS.

Autor: Chamba, C. C., Ntemi, P., Schuh, A., Cuts, A., Balandya, E., Vavoulis, D., Dreau, H., Burns, A., Howard, K., Rideout, K., Mkwizu, E., Mwamtemi, H., Ogwang, M., Legason, I., Mawalla, W., Christopher, H., Saukiwa, E., Shungu, R.
Předmět:
Zdroj: Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p334-335, 2p
Abstrakt: B Introduction: b Burkitt Lymphoma (BL) is an aggressive B- cell malignancy that is highly prevalent in Sub-Saharan Africa (SSA), contributing to 50% of paediatric cancer. We developed a liquid biopsy test for the detection of EBL that complements tissue histopathology while circumventing these challenges. An accurate diagnosis of BL via immunohistochemistry is dependent upon obtaining a tissue biopsy. [Extracted from the article]
Databáze: Complementary Index